Neurochemical modulators of sleep and anesthetic states

International Anesthesiology Clinics

Volumn 46, Issue 3, 2008, Pages 75-104

  Van Dort, Christa J ^a   Baghdoyan, Helen A ^a   Lydic, Ralph ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ADENOSINE; ANESTHETIC AGENT; DESFLURANE; ETOMIDATE; GALANIN; GLUTAMIC ACID; GLYCINE; HISTAMINE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MIDAZOLAM; MONOAMINE; NEUROTRANSMITTER; NITROUS OXIDE; NORADRENALIN; OREXIN; PENTOBARBITAL; PROPOFOL; SEROTONIN; SEVOFLURANE; XENON; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANESTHESIA (SENSORY DYSFUNCTION); CLINICAL PRACTICE; HUMAN; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REM SLEEP; REVIEW; SLEEP; WAKEFULNESS; ANIMAL; CHEMICALLY INDUCED DISORDER; CONSCIOUSNESS; DRUG EFFECT; GENERAL ANESTHESIA; PHYSIOLOGY; UNCONSCIOUSNESS;

ACETYLCHOLINE; ANESTHESIA, GENERAL; ANESTHETICS; ANIMALS; CONSCIOUSNESS; HUMANS; NEUROTRANSMITTER AGENTS; SLEEP; UNCONSCIOUSNESS; WAKEFULNESS;

EID: 53449096990     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/AIA.0b013e318181a8ca     Document Type: Review

References (193)

1. Blackmore SJ. Consciousness: an introduction. Oxford, NY: Oxford University Press; 2004.
2. Gallagher II. Philosophical conceptions of the self: implications for cognitive science. Trends Cogn Sci. 2000;4:14-21.
3. Koch C. The quest for consciousness: a neurobiological approach. Denver, CO: Roberts and Co; 2004.
4. Hobson JA, Pace-Schott EF, Stickgold R. Consciousness: its vicissitudes in waking and sleep: an integration of recent neurophysiological and neuropsychological evidence. In: Gazzaniga M, ed. The New Cognitive Neurosciences. 2nd edn. Cambridge, MA: MIT Press; 1999:1341-1354.
5. Hobson JA, Pace-Schott EF. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci. 2002;3:679-693.
6. Hobson JA, Pace-Schott EF, Stickgold R. Dreaming and the brain: toward a cognitive neuroscience of conscious states. Behav Brain Sci. 2000;23:793-842.
7. Lydic R. Reticular modulation of breathing during sleep and anesthesia. Curr Opin Pulm Med. 1996;2:474-481.
8. Lydic R, Baghdoyan HA. Cholinergic contributions to the control of consciousness. In: Yaksh TL, Lynch C, Zapol WM, et al, eds. Anesthesia: Biologic Foundations. NY: Lippincott Raven; 1998:433-450.
9. Fiset P. Research on anesthesia, consciousness or both? Understanding our anesthetic drugs and defining the neural substrate. Can J Anesth. 2003;50:R1-R5.
10. Hudetz AG, Wood JD, Kampine JP. Cholinergic reversal of isoflurane anesthesia in rats as measured by cross-approximate entropy of the electroencephalogram. Anesthesiology. 2003;99:1125-1131.
11. Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A. 2008;105:1309-1314.
12. Lydic R, Baghdoyan HA. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology. 2005;103:1268-1295.
13. Meuret P, Backman SB, Bonhomme V, et al. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology. 2000;93:708-717.
14. Nelson LE, Guo TZ, Lu J, et al. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci. 2002;5:979-984.
15. Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428-436.
16. Pain L, Jeltsch H, Lehmann O, et al. Central cholinergic depletion induced by 192 IgG-saporin alleviates the sedative effects of propofol in rats. Br J Anaesth. 2000;85: 869-873.
17. Tung A, Herrera S, Szafran MJ, et al. Effect of sleep deprivation on righting reflex in the rat is partially reversed by administration of adenosine A1 and A2 receptor antagonists. Anesthesiology. 2005;102:1158-1164.
18. Yasuda Y, Takeda A, Fukuda S, et al. Orexin A elicits arousal electroencephalo-graphy without sympathetic cardiovascular activation in isoflurane-anesthetized rats. Anesth Analg. 2003;97:1663-1666.
19. Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci. 2008;9:370-386.
20. Massimini M, Ferrarelli F, Huber R, et al. Breakdown of cortical effective connectivity during sleep. Science. 2005;309:2228-2232.
21. Lydic R, Baghdoyan HA. Sleep and anesthesia. In: Hemmings HC, Hopkins PM, eds. Foundations of Anesthesia: Basic and Clinical Sciences. Philadephia, PA: Mosby/ Elsevier; 2005:361-371.
22. Lydic R, Baghdoyan HA. Anesthesiology: relevance for sleep medicine. In: Lee-Chiong TL, ed. Encyclopedia of Sleep Medicine. Hoboken, NJ: John Wiley & Sons, 2005:927-932.
23. Tung A, Mendelson WB. Anesthesia and sleep. Sleep Med Rev. 2004;8:213-225.
24. Lydic R, Baghdoyan HA. Neurochemical mechanisms mediating opioid-induced REM sleep distruption. In: Lavigne G, Sessle BJ, Choinière M, et al, eds. Sleep and Pain. Seattle, WA: International Association for the Study of Pain (IASP) Press; 2007:99-122.
25. Steriade M, McCarley RW. Brain Control of Wakefulness and Sleep. Second ed. New York: Plenum Press; 2005.
26. Reves JG, Glass PSA, Lubarsky DA, et al. Intravenous nonopioid anesthetics. In: Miller RD, ed. Miller's Anesthesia. 6th edn. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:317-378.
27. Muzur A, Pace-Schott EF, Hobson JA. The prefrontal cortex in sleep. Trends Cogn Sci. 2002;6:475-481.
28. Bjorvatn B, Gronli J, Hamre F, et al. Effects of sleep deprivation on extracellular serotonin in hippocampus and frontal cortex of the rat. Neuroscience. 2002;113: 323-330.
29. Lena I, Parrot S, Deschaux O, et al. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep - wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res. 2005;81:891-899.
30. Shouse MN, Staba RJ, Saquib SF, et al. Monoamines and sleep: microdialysis findings in pons and amygdala. Brain Res. 2000;860:181-189.
31. Pain L, Gobaille S, Schleef C, et al. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg. 2002;95:915-919.
32. A and NMDA receptors. Br J Anaesth. 2000;84:250-253.
33. Shyr MH, Tsai TH, Yang CH, et al. Propofol anesthesia increases dopamine and serotonin activities at the somatosensory cortex in rats: a microdialysis study. Anesth Analg. 1997;84:1344-1348.
34. Myburgh JA, Upton RN, Grant C, et al. Epinephrine, norepinephrine and dopamine infusions decrease propofol concentrations during continuous propofol infusion in an ovine model. Intensive Care Med. 2001;27:276-282.
35. Kushikata T, Hirota K, Yoshida H, et al. Alpha-2 adrenoceptor activity affects propofol-induced sleep time. Anesth Analg. 2002;94:1201-1206.
36. A receptors are critical targets for sedative-hypnotic drugs. J Clin Sleep Med. 2006;2:S12-S18.
37. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol Sci. 2000;21:16-19.
38. A receptors. Trends Neurosci. 2004;27:569-575.
39. A receptor modulation by propofol. Neuropharmacology. 1997;36:941-949.
40. A receptor beta subunit and vary in their interaction with actin. Acta Anaesthesiol Scand. 2003;47:157-164.
41. Xi MC, Morales FR, Chase MH. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol. 1999;82: 2015-2019.
42. Sanford LD, Tang X, Xiao J, et al. GABAergic regulation of REM sleep in reticularis pontis oralis and caudalis in rats. J Neurophysiol. 2003;90:938-945.
43. Watson CJ, Soto-Calderon H, Lydic R, et al. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep 2008;31:453-464.
44. Nitz D, Siegel J. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am J Physiol. 1997;273:R451-R455.
45. A receptors by propofol and its potentiation by pentobarbital or alphaxalone. Eur J Pharmacol. 1999;386:201-210.
46. A receptor blockade antagonizes the immobilizing action of propofol but not ketamine or isoflurane in a dose-related manner. Anesth Analg. 2003;96:706-712.
47. Dam M, Ori C, Pizzolato G, et al. The effects of propofol anesthesia on local cerebral glucose utilization in the rat. Anesthesiology. 1990;73:499-505.
48. Alkire MT, Haier RJ, Barker SJ, et al. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology. 1995;82:393-403.
49. Peduto VA, Concas A, Santoro G, et al. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology. 1991;75:1000-1009.
50. Braestrup C, Albrechtsen R, Squires RF. High densities of benzodiazepine receptors in human cortical areas. Nature. 1977;269:702-704.
51. Datta S, Spoley EE, Patterson EH. Microinjection of glutamate into the pedunculopontine tegmentum induces REM sleep and wakefulness in the rat. Am J Physiol Regul Integr Comp Physiol. 2001;280:R752-R759.
52. Kodama T, Honda Y. Acetylcholine and glutamate release during sleep-wakefulness in the pedunculopontine tegmental nucleus and norepinephrine changes regulated by nitric oxide. Psychiatry Clin Neurosci. 1999;53:109-111.
53. Stutzmann JM, Lucas M, Blanchard JC, et al. Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats. Neurosci Lett. 1988;88:195-200.
54. Prospero-Garcia O, Criado JR, Henriksen SJ. Pharmacology of ethanol and glutamate antagonists on rodent sleep: a comparative study. Pharmacol Biochem Behav. 1994;49:413-416.
55. Lopez-Rodriguez F, Medina-Ceja L, Wilson CL, et al. Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness. Arch Med Res. 2007;38:52-55.
56. Bettendorff L, Sallanon-Moulin M, Touret M, et al. Paradoxical sleep deprivation increases the content of glutamate and glutamine in rat cerebral cortex. Sleep. 1996;19:65-71.
57. Cape EG, Jones BE. Effects of glutamate agonist versus procaine microinjections into the basal forebrain cholinergic cell area upon gamma and theta EEG activity and sleep-wake state. Eur J Neurosci. 2000;12:2166-2184.
58. Lingamaneni R, Birch ML, Hemmings HC Jr. Widespread inhibition of sodium channel-dependent glutamate release from isolated nerve terminals by isoflurane and propofol. Anesthesiology. 2001;95:1460-1466.
59. Ratnakumari L, Hemmings HC Jr. Effects of propofol on sodium channel-dependent sodium influx and glutamate release in rat cerebrocortical synaptosomes. Anesthesiology. 1997;86:428-439.
60. Westphalen RI, Hemmings HC Jr. Effects of isoflurane and propofol on glutamate and GABA transporters in isolated cortical nerve terminals. Anesthesiology. 2003;98:364-372.
61. Westphalen RI, Hemmings HC Jr. Selective depression by general anesthetics of glutamate versus GABA release from isolated cortical nerve terminals. J Pharmacol Exp Ther. 2003;304:1188-1196.
62. Orser BA, Bertlik M, Wang LY, et al. Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol. 1995;116:1761-1768.
63. Backman SB, Fiset P, Plourde G. Cholinergic mechanisms mediating anesthetic induced altered states of consciousness. Prog Brain Res. 2004;145:197-206.
64. Leonard TO, Lydic R. Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate. J Neurosci. 1997;17:774-785.
65. Lydic R, Douglas CL, Baghdoyan HA. Microinjection of neostigmine into the pontine reticular formation of C57BL/6J mouse enhances rapid eye movement sleep and depresses breathing. Sleep. 2002;25:835-841.
66. Bourgin P, Escourrou P, Gaultier C, et al. Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport. 1995; 6:532-536.
67. Baghdoyan HA, Monaco AP, Rodrigo-Angulo ML, et al. Microinjection of neostigmine into the pontine reticular formation of cats enhances desynchronized sleep signs. J Pharmacol Exp Ther. 1984;231:173-180.
68. Nagase Y, Kaibara M, Uezono Y, et al. Propofol inhibits muscarinic acetylcholine receptor-mediated signal transduction in Xenopus Oocytes expressing the rat M1 receptor. Jpn J Pharmacol. 1999;79:319-325.
69. Flood P, Ramirez-Latorre J, Role L. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology. 1997;86:859-865.
70. Furuya R, Oka K, Watanabe I, et al. The effects of ketamine and propofol on neuronal nicotinic acetylcholine receptors and P2x purinoceptors in PC12 cells. Anesth Analg. 1999;88:174-180.
71. Marrosu F, Portas C, Mascia MS, et al. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res. 1995;671:329-332.
72. Kikuchi T, Wang Y, Sato K, et al. In vivo effects of propofol on acetylcholine release from the frontal cortex, hippocampus and striatum studied by intracerebral microdialysis in freely moving rats. Br J Anaesth. 1998;80:644-648.
73. Tung A, Bluhm B, Mendelson WB. The hypnotic effect of propofol in the medial preoptic area of the rat. Life Sci. 2001;69:855-862.
74. Tung A, Szafran MJ, Bluhm B, et al. Sleep deprivation potentiates the onset and duration of loss of righting reflex induced by propofol and isoflurane. Anesthesiology. 2002;97:906-911.
75. Basheer R, Strecker RE, Thakkar MM, et al. Adenosine and sleep-wake regulation. Prog Neurobiol. 2004;73:379-396.
76. Tohdoh Y, Narimatsu E, Kawamata M, et al. The involvement of adenosine neuromodulation in pentobarbital-induced field excitatory postsynaptic potentials depression in rat hippocampal slices. Anesth Analg. 2000;91:1537-1541.
77. Tung A, Bergmann BM, Herrera S, et al. Recovery from sleep deprivation occurs during propofol anesthesia. Anesthesiology. 2004;100:1419-1426.
78. Corssen G, Domino EF. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth Analg. 1966;45:29-40.
79. Domino EF, Chodoff P, Corssen G. Pharmacologic Effects of Ci-581, a New Dissociative Anesthetic, in Man. Clin Pharmacol Ther. 1965;6:279-291.
80. Lydic R, Baghdoyan HA. Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep. Sleep. 2002;25: 617-622.
81. White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology. 1982;56:119-136.
82. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998;87:1186-1193.
83. Aalto S, Ihalainen J, Hirvonen J, et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl). 2005;182:375-383.
84. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, et al. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry. 2000;48:627-640.
85. Moghaddam B, Adams B, Verma A, et al. Activation of glutamatergic neurotrans-mission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci. 1997;17:2921-2927.
86. Smith GS, Schloesser R, Brodie JD, et al. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects. Neuropsychopharmacology. 1998;18:18-25.
87. Lindefors N, Barati S, O'Connor WT. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Res. 1997;759:205-212.
88. Lorrain DS, Baccei CS, Bristow LJ, et al. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience. 2003;117:697-706.
89. Masuzawa M, Nakao S, Miyamoto E, et al. Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: a microdialysis study. Anesth Analg. 2003;96:148-152.
90. 1A dopamine receptors. Brain Res. 2001;894:167-180.
91. 2 receptor. Biol Psychiatry. 2001;49:954-957.
92. Jordan S, Chen R, Fernalld R, et al. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors. Eur J Pharmacol. 2006;540:53-56.
93. Nader MA, Grant KA, Gage HD, et al. PET imaging of dopamine D2 receptors with [18F]fluoroclebopride in monkeys: effects of isoflurane and ketamine-induced anesthesia. Neuropsychopharmacology. 1999;21:589-596.
94. Nishimura M, Sato K. Ketamine stereoselectively inhibits rat dopamine transporter. Neurosci Lett. 1999;274:131-134.
95. Kubota T, Anzawa N, Hirota K, et al. Effects of ketamine and pentobarbital on noradrenaline release from the medial prefrontal cortex in rats. Can J Anaesth. 1999;46:388-392.
96. A receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg. 2000;91:230-236.
97. Flood P, Krasowski MD. Intravenous anesthetics differentially modulate ligand-gated ion channels. Anesthesiology. 2000;92:1418-1425.
98. Tomiya M, Fukushima T, Kawai J, et al. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine. Biomed Chromatogr. 2006;20:628-633.
99. Sakai F, Amaha K. Midazolam and ketamine inhibit glutamate release via a cloned human brain glutamate transporter. Can J Anaesth. 2000;47:800-806.
100. Razoux F, Garcia R, Lena I. Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology. 2007;32:719-727.
101. Rowland LM, Bustillo JR, Mullins PG, et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry. 2005;162:394-396.
102. Coates KM, Flood P. Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcho-line receptors in Xenopus oocytes. Br J Pharmacol. 2001;134:871-879.
103. Yamakura T, Chavez-Noriega LE, Harris RA. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine. Anesthesiology. 2000; 92:1144-1153.
104. Ho KK, Flood P. Single amino acid residue in the extracellular portion of transmembrane segment 2 in the nicotinic alpha7 acetylcholine receptor modulates sensitivity to ketamine. Anesthesiology. 2004;100:657-662.
105. Sasaki T, Andoh T, Watanabe I, et al. Nonstereoselective inhibition of neuronal nicotinic acetylcholine receptors by ketamine isomers. Anesth Analg. 2000;91: 741-748.
106. Durieux ME. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg. 1995;81:57-62.
107. Morita T, Hitomi S, Saito S, et al. Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice. Psychopharmacology (Berl). 1995;117: 396-402.
108. Kikuchi T, Wang Y, Shinbori H, et al. Effects of ketamine and pentobarbitone on acetylcholine release from the rat frontal cortex in vivo. Br J Anaesth. 1997;79: 128-130.
109. Nelson CL, Burk JA, Bruno JP, et al. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology (Berl). 2002;161:168-179.
110. Mashour GA. Monitoring consciousness: EEG-based measures of anesthetic depth. Semin Anesth Periop Med Pain. 2006;25:205-210.
111. Mandryk M, Fidecka S, Poleszak E, et al. Participation of adenosine system in the ketamine-induced motor activity in mice. Pharmacol Rep. 2005;57:55-60.
112. Eger EI II. Isoflurane: a review. Anesthesiology. 1981;55:559-576.
113. Berger AJ, Bayliss DA, Viana F. Modulation of neonatal rat hypoglossal motoneuron excitability by serotonin. Neurosci Lett. 1992;143:164-168.
114. Brandes IF, Zuperku EJ, Stucke AG, et al. Isoflurane depresses the response of inspiratory hypoglossal motoneurons to serotonin in vivo. Anesthesiology. 2007;106: 736-745.
115. Whittington RA, Virag L. Isoflurane decreases extracellular serotonin in the mouse hippocampus. Anesth Analg. 2006;103:92-98.
116. Georgiev SK, Wakai A, Kohno T, et al. Actions of norepinephrine and isoflurane on inhibitory synaptic transmission in adult rat spinal cord substantia gelatinosa neurons. Anesth Analg. 2006;102:124-128.
117. Kumar VM, Vetrivelan R, Mallick HN. Noradrenergic afferents and receptors in the medial preoptic area: neuroanatomical and neurochemical links between the regulation of sleep and body temperature. Neurochem Int. 2007;50:783-790.
118. Kushikata T, Hirota K, Kotani N, et al. Isoflurane increases norepinephrine release in the rat preoptic area and the posterior hypothalamus in vivo and in vitro: relevance to thermoregulation during anesthesia. Neuroscience. 2005;131:79-86.
119. Passani MB, Giannoni P, Bucherelli C, et al. Histamine in the brain: beyond sleep and memory. Biochem Pharmacol. 2007;73:1113-1122.
120. Hashimoto Y, Hashimoto Y, Hirota K, et al. Inhibited hypothalamic histamine metabolism during isoflurane and sevoflurane anesthesia in rats. Acta Anaesthesiol Scand. 1998;42:858-863.
121. Gallopin T, Fort P, Eggermann E, et al. Identification of sleep-promoting neurons in vitro. Nature. 2000;404:992-995.
122. Isaac SO, Berridge CW. Wake-promoting actions of dopamine D1 and D2 receptor stimulation. J Pharmacol Exp Ther. 2003;307:386-394.
123. Adachi YU, Yamada S, Satomoto M, et al. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum. Brain Res Bull. 2005;67: 176-181.
124. Adachi YU, Yamada S, Satomoto M, et al. Isoflurane anesthesia inhibits clozapine-and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study. Neurochem Int. 2008;52:384-391.
125. Keita H, Henzel-Rouelle D, Dupont H, et al. Halothane and isoflurane increase spontaneous but reduce the N-methyl-D-aspartate-evoked dopamine release in rat striatal slices: evidence for direct presynaptic effects. Anesthesiology. 1999;91: 1788-1797.
126. Wisor JP, Nishino S, Sora I, et al. Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 2001;21:1787-1794.
127. Votaw J, Byas-Smith M, Hua J, et al. Interaction of isoflurane with the dopamine transporter. Anesthesiology. 2003;98:404-411.
128. Votaw JR, Byas-Smith MG, Voll R, et al. Isoflurane alters the amount of dopamine transporter expressed on the plasma membrane in humans. Anesthesiology. 2004;101:1128-1135.
129. Byas-Smith MG, Li J, Szlam F, et al. Isoflurane induces dopamine transporter trafficking into the cell cytoplasm. Synapse. 2004;53:68-73.
130. Bortone L, Ingelmo P, Grossi S, et al. Emergence agitation in preschool children: double-blind, randomized, controlled trial comparing sevoflurane and isoflurane anesthesia. Paediatr Anaesth. 2006;16:1138-1143.
131. Irifune M, Sato T, Nishikawa T, et al. Hyperlocomotion during recovery from isoflurane anesthesia is associated with increased dopamine turnover in the nucleus accumbens and striatum in mice. Anesthesiology. 1997;86:464-475.
132. Mashour GA, Forman SA, Campagna JA. Mechanisms of general anesthesia: from molecules to mind. Best Pract Res Clin Anaesthesiol. 2005;19:349-364.
133. Hapfelmeier G, Haseneder R, Eder M, et al. Isoflurane slows inactivation kinetics of rat recombinant alpha1beta2gamma2L GABA(A) receptors: enhancement of GABA ergic transmission despite an open-channel block. Neurosci Lett. 2001;307:97-100.
134. Ming Z, Knapp DJ, Mueller RA, et al. Differential modulation of GABA- and NMDA-gated currents by ethanol and isoflurane in cultured rat cerebral cortical neurons. Brain Res. 2001;920:117-124.
135. Liachenko S, Tang P, Somogyi GT, et al. Concentration-dependent isoflurane effects on depolarization-evoked glutamate and GABA outflows from mouse brain slices. Br J Pharmacol. 1999;127:131-138.
136. Gyulai FE, Mintun MA, Firestone LL. Dose-dependent enhancement of in vivo GABA(A)-benzodiazepine receptor binding by isoflurane. Anesthesiology. 2001;95: 585-593.
137. Zhang Y, Wu S, Eger EI II, et al. Neither GABAA nor strychnine-sensitive glycine receptors are the sole mediators of MAC for isoflurane. Anesth Analg. 2001;92: 123-127.
138. Nitz D, Siegel JM. GABA release in the locus coeruleus as a function of sleep/wake state. Neuroscience. 1997;78:795-801.
139. Nitz D, Siegel JM. GABA release in posterior hypothalamus across sleep-wake cycle. Am J Physiol. 1996;271:R1707-R1712.
140. Dong HL, Fukuda S, Murata E, et al. Excitatory and inhibitory actions of isoflurane on the cholinergic ascending arousal system of the rat. Anesthesiology. 2006;104:122-133.
141. Vanini G, Watson CJ, Bouchard LA, et al. GABA levels in substania innominata (SI) of cat basal forebrain are state dependent. Sleep 2007;30 (abstract supplement):A3.
142. Freund TF, Gulyas AI. GABAergic interneurons containing calbindin D28K or somatostatin are major targets of GABAergic basal forebrain afferents in the rat neocortex. J Comp Neurol. 1991;314:187-199.
143. Freund TF, Meskenaite V. gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex. Proc Natl Acad Sci USA. 1992;89:738-742.
144. Manns ID, Alonso A, Jones BE. Discharge profiles of juxtacellularly labeled and immunohistochemically identified GABAergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats. J Neurosci. 2000;20: 9252-9263.
145. A receptor alpha(1) subunit with near-normal apparent affinity for GABA: characterization in heterologous systems and production of knockin mice. J Pharmacol Exp Ther. 2006;319:208-218.
146. A receptors expressed in Sf9 cells. Eur J Pharmacol. 1999;378:223-231.
147. A-receptor channels. Anesth Analg. 2000;90: 1184-1190.
148. A receptors modulate the capacity of isoflurane to produce immobility. Anesth Analg. 2001;92:1585-1589.
149. A receptors. Eur J Pharmacol. 2005;516: 23-27.
150. Larsen M, Valo ET, Berg-Johnsen J, et al. Isoflurane reduces synaptic glutamate release without changing cytosolic free calcium in isolated nerve terminals. Eur J Anaesthesiol. 1998;15:224-229.
151. Winegar BD, MacIver MB. Isoflurane depresses hippocampal CA1 glutamate nerve terminals without inhibiting fiber volleys. BMC Neurosci. 2006;7:5.
152. Zuo Z. Isoflurane enhances glutamate uptake via glutamate transporters in rat glial cells. Neuroreport. 2001;12:1077-1080.
153. Cechova S, Zuo Z. Inhibition of glutamate transporters increases the minimum alveolar concentration for isoflurane in rats. Br J Anaesth. 2006;97:192-195.
154. Larsen M, Hegstad E, Berg-Johnsen J, et al. Isoflurane increases the uptake of glutamate in synaptosomes from rat cerebral cortex. Br J Anaesth. 1997; 78:55-59.
155. Huang Y, Zuo Z. Isoflurane enhances the expression and activity of glutamate transporter type 3 in C6 glioma cells. Anesthesiology. 2003;99:1346-1353.
156. Huang Y, Feng X, Sando JJ, et al. Critical role of serine 465 in isoflurane-induced increase of cell-surface redistribution and activity of glutamate transporter type 3. J Biol Chem. 2006;281:38133-38138.
157. Dickinson R, Peterson B, Banks P, et al. Competitive Inhibition at the Glycine Site of the N-Methyl-D-aspartate Receptor by the Anesthetics Xenon and Isoflurane. Anestheisology. 2007;107:756-767.
158. Violet JM, Downie DL, Nakisa RC, et al. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology. 1997;86:866-874.
159. Yamashita M, Mori T, Nagata K, et al. Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells. Anesthesiology. 2005;102:76-84.
160. Flood P, Coates KM. Sensitivity of the alpha7 nicotinic acetylcholine receptor to isoflurane may depend on receptor inactivation. Anesth Analg. 2002;95:83-87.
161. Matsuura T, Kamiya Y, Itoh H, et al. Inhibitory effects of isoflurane and nonimmobilizing halogenated compounds on neuronal nicotinic acetylcholine receptors. Anesthesiology. 2002;97:1541-1549.
162. Nietgen GW, Honemann CW, Chan CK, et al. Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function. Br J Anaesth. 1998;81:569-577.
163. Do SH, Kamatchi GL, Durieux ME. The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C. Anesth Analg. 2001;93:375-381.
164. Shichino T, Murakawa M, Adachi T, et al. Effects of isoflurane on in vivo release of acetylcholine in the rat cerebral cortex and striatum. Acta Anaesthesiol Scand. 1997;41:1335-1340.
165. Keifer JC, Baghdoyan HA, Lydic R. Pontine cholinergic mechanisms modulate the cortical electroencephalographic spindles of halothane anesthesia. Anesthesiology. 1996;84:945-954.
166. Jansson A, Olin K, Yoshitake T, et al. Effects of isoflurane on prefrontal acetylcholine release and hypothalamic Fos response in young adult and aged rats. Exp Neurol. 2004;190:535-543.
167. Segerdahl M, Ekblom A, Sandelin K, et al. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg. 1995;80: 1145-1149.
168. Segerdahl M, Persson E, Ekblom A, et al. Peroperative adenosine infusion reduces isoflurane concentrations during general anesthesia for shoulder surgery. Acta Anaesthesiol Scand. 1996;40:792-797.
169. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr Opin Pharmacol. 2008;8:2-7.
170. Liu Y, Xiong L, Chen S, et al. Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can J Anaesth. 2006;53:194-201.
171. Tas PW, Eisemann C, Roewer N. The volatile anesthetic isoflurane suppresses spontaneous calcium oscillations in vitro in rat hippocampal neurons by activation of adenosine A1 receptors. Neurosci Lett. 2003;338:229-232.
172. Vlajkovic GP, Sindjelic RP. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;104:84-91.
173. 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science. 1982;215:1394-1396.
174. Yasui Y, Masaki E, Kato F. Sevoflurane directly excites locus coeruleus neurons of rats. Anesthesiology. 2007;107:992-1002.
175. Anzawa N, Kushikata T, Ohkawa H, et al. Increased noradrenaline release from rat preoptic area during and after sevoflurane and isoflurane anesthesia. Can J Anaesth. 2001;48:462-465.
176. Silva JH, Gomez RS, Diniz PH, et al. The effect of sevoflurane on the release of [3H]dopamine from rat brain cortical slices. Brain Res Bull. 2007;72:309-314.
177. A receptors: implications for an enhanced GABAergic transmission. Eur J Anaesthesiol. 2001; 18:377-383.
178. Kira T, Harata N, Sakata T, et al. Kinetics of sevoflurane action on GABA- and glycine-induced currents in acutely dissociated rat hippocampal neurons. Neuroscience. 1998;85:383-394.
179. Nishikawa K, Kubo K, Ishizeki J, et al. The interaction of noradrenaline with sevoflurane on GABA(A) receptor-mediated inhibitory postsynaptic currents in the rat hippocampus. Brain Res. 2005;1039:153-161.
180. Moe MC, Berg-Johnsen J, Larsen GA, et al. Sevoflurane reduces synaptic glutamate release in human synaptosomes. J Neurosurg Anesthesiol. 2002;14:180-186.
181. Vinje ML, Moe MC, Valo ET, et al. The effect of sevoflurane on glutamate release and uptake in rat cerebrocortical presynaptic terminals. Acta Anaesthesiol Scand. 2002;46:103-108.
182. Scheller M, Bufler J, Schneck H, et al. Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations. Anesthesiology. 1997;86:118-127.
183. White NS, Alkire MT. Impaired thalamocortical connectivity in humans during general-anesthetic-induced unconsciousness. Neuroimage. 2003;19:402-411.
184. Gallezot JD, Bottlaender M, Gregoire MC, et al. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET. J Nucl Med. 2005;46:240-247.
185. Alkire MT, McReynolds JR, Hahn EL, et al. Thalamic microinjection of nicotine reverses sevoflurane-induced loss of righting reflex in the rat. Anesthesiology. 2007;107:264-272.
186. Mashour GA. Integrating the science of consciousness and anesthesia. Anesth Analg. 2006;103:975-982.
187. Nofzinger EA. Neuroimaging of sleep and sleep disorders. Curr Neurol Neurosci Rep. 2006;6:149-155.
188. Tononi G. Consciousness, information integration, and the brain. Prog Brain Res. 2005;150:109-126.
189. Plum F, Posner JB. The diagnosis of stupor and coma. 3rd edn. Philadelphia: F. A. Davis Co; 1980:1-373.
190. Hobson JA. What is a behavioral state? In: Ferrendelli JA, ed. Neuroscience Symposia: Aspects of Behavioral Neurobiology. Vol. 3. Bethesda, MD: Society for Neuroscience; 1978:1-15.
191. McGuire BE, Basten CJ, Ryan CJ, et al. Intensive care unit syndrome: a dangerous misnomer. Arch Intern Med. 2000;160:906-909.
192. Paton WD. How far do we understand the mechanism of anaesthesia? Eur J Anaesthesiol. 1984;1:93-103.
193. Mashour GA. Consciousness unbound: toward a paradigm of general anesthesia. Anesthesiology. 2004;100:428-433.